Zensights LLC

We are pleased to spotlight Laura Mezey, a valued Subject Matter Expert with Zensights: Laura’s extensive background in legal and compliance, M&A strategy, integration planning, and divestiture management spans over two decades, primarily at Bayer HealthCare. In her tenure at Bayer, Laura held significant leadership roles, including Vice President of Integration, Separation, and Transitions, and Global Division Counsel. Throughout her tenure at Bayer, Laura was instrumental in shaping and executing strategic initiatives across two global healthcare divisions, encompassing pharma, medical devices, diagnostics, and software. Her deep expertise in M&A strategy, integration planning, and divestiture management has been key in driving successful business transformations and cultural changes. Laura's career has been marked by her innovative approach to legal and compliance challenges, as well as her ability to navigate complex, cross-functional issues in a highly regulated industry. As the first lawyer dedicated to Bayer's Diabetes Care business, she played a crucial role in its evolution, from supporting the division’s growth to managing its divestiture. Laura’s work extended beyond legal counsel; she was a vital member of the global management team, contributing to strategic decisions that impacted the company's direction on a global scale. Laura led a team responsible for executing integration and separation strategies for Bayer’s significant transactions. She was the architect behind the company’s divestiture playbook, a comprehensive guide that has informed and improved subsequent transactions. Her pragmatic problem-solving skills, coupled with a forward-thinking mindset, have made her a trusted advisor in both high-growth and commoditizing business environments.   Laura's impact extends beyond her time at Bayer. She currently serves on the Board of Directors for Otsuka America Pharmaceuticals and as an Entrepreneur in Residence at DigitalDx Ventures, where she continues to contribute her strategic insights to the life sciences sector. We are lucky to have Laura on board and grateful for the valuable expertise she brings to our clients – if your organization is going through separations or integrations, there is no better individual than Laura to provide learned strategic guidance. #ZensightsSME #MAStrategy #IntegrationPlanning #SubjectMatterExpert

Private Equity Continues to Invest in Pharma Patient Services/HUB Companies. Notably this year, PharmaCord, AssistRX, and CoPilot have had Private Equity take partial or complete ownership in their organizations. These transactions are potentially impactful when/if key leadership rotates out of the organization. It is important to understand the strategic long term vision of these PE acquisitions — You should always be aware of ownership changes within the vendors you consider key strategic partners. Zensights can assist you in navigating and understanding the potential implications of these and other variables associated with Patient Services and HUB vendors. #PrivateEquityInPharma #PatientServices #HUB #Zensights

The name "Betsy Bondurant" is synonymous with "Gold Standard" when it comes to Strategic Meetings Management; there is no one else you'd rather have on your team. Given that, we're thrilled to announce that she's joined ours — Betsy is joining Zensights as a Subject Matter Expert. Betsy brings a unique 360° perspective with over 30 years of industry expertise in meeting & trade show management and procurement, including 20 years dedicated to Strategic Meetings Management (SMM). Her journey began in hotel sales and management, and in 1992 she moved to Amgen to run their Meetings and Trade Shows. During her 15-year tenure at Amgen, she developed and implemented a pioneering corporate-wide SMM program, showcasing her ability to lead and innovate within the industry.    In 2007, Betsy transitioned into consulting, leveraging her vast experience to provide unbiased appraisals and recommendations for SMM programs. Her expertise is widely recognized, making her a sought-after consultant, speaker and author. She has shared her insights on strategic meeting management, stakeholder management, and alignment with audiences across North America, Central America, Europe, and Asia. Betsy's dedication to policy work, data analysis, and benchmarking will be invaluable as she guides organizations in achieving consistent, high-quality outcomes for their events.    Betsy has been a driving force in the industry, holding significant roles in various associations. She served on the Global Business Travel Association (GBTA) Meetings committee, most recently as Vice-Chair, and was the 2023 Chair for the Events Industry Council (EIC) APEX Commission. Her long-standing involvement with Meeting Professionals International (MPI), including a three-year tenure on their International Board of Directors, underscores her commitment to advancing the industry. As a Certified Travel Executive (CTE) and Certified Meeting Manager (CMM), her credentials further demonstrate her authority in the field. Throughout her career, Betsy has received numerous accolades, including the GBTA “Presidents Award” in 2021, Business Travel News Best Practitioner of the Year Award, Meeting News “25 Most Influential People in the Meetings Industry,” and MPI Chairwoman's award.   With all that said, it’s easy to understand why we are honored to have Betsy join the Zensights team. Betsy will continue to apply her strategic expertise, particularly in procurement and meetings management, helping clients optimize their supplier base, manage RFP processes, and drive cost efficiencies. Please join us in welcoming Betsy! #ZensightsSME #StrategicMeetingsManagement #MeetingsAndEvents

We are excited to welcome Karen Lynch to our team as a Subject Matter Expert joining Zensights. With over 20 years of corporate and consulting experience, Karen is a highly skilled executive coach, facilitator, and management consultant. Her extensive training across and expertise in emotional intelligence, leadership development, and change management makes her an invaluable addition to our team, particularly as it pertains to her experience guiding companies through assessments and change across the healthcare and pharmaceutical sectors.   Karen’s career began with American Express, where she developed deep expertise from various roles in meetings, events and tradeshows. Her leadership in operations, account management and global business development garnered her a 360 view into M&E. Over her 17 years there, Karen gained a comprehensive understanding across all industries, including manufacturing, technology, professional services, financial, retail, and healthcare. This diverse background laid the foundation for her transition into consulting, where she has implemented global programs and events for many companies, focusing on strategic processes and policy support for change management initiatives.   Now leading both a leadership development and a change management company, Karen has dedicated herself to her pivotal role. With over 2000 hours of coaching expertise, she is a Professional Certified Coach (PCC), as well as a Change Management Practitioner, working with senior executives, leaders, and teams to enhance leadership skills and both personal and organizational effectiveness. Within pharma, she particularly enjoys the process of identifying and implementing opportunities for change. On behalf of pharma clients, she has run several Global Assessments, interviewing stakeholders to gauge satisfaction and policy adherence. Research, benchmarking, payment process, organizational structure, technology roadmap, resource modeling, and pitch development are some of her key areas of expertise. Her work underscores the growing integration of marketing and event management, recognizing the interdependence where marketing drives revenue and meetings drive process, ensuring cohesive execution across the board.   Karen's ability to integrate strategic planning with personal development will be instrumental in helping pharmaceutical companies navigate the complexities of organizational change and leadership development. We are thrilled to have Karen on board and welcome her into our community. #ZensightsSME #MeetingsAndEvents #LeadershipDevelopment

Here’s what you need to know about Life Science M&A activity in Q2 2024: ✓ Slower M&A Activity: This quarter, we observed five acquisitions within our monitored life science markets, maintaining the same level as Q2 last year but trending below the average over the past two years. This could indicate a cyclical dip or a broader slowdown in merger activity. ✓ Strategic Consolidation: Companies are increasingly merging to expand capabilities. Q2 deals prominently featured the integration of health-related PR with medical communications and omnichannel services, showing a market shift towards comprehensive solutions over fragmented services. ✓ Cross-Industry Integration: The trend of merging non-healthcare capabilities with healthcare-specific suppliers continues. While this approach has seen mixed results in the past, it remains a strategic focus for many companies aiming for diversified service offerings. ✓ Private Equity Movements: Interestingly, there’s been a reduction in private equity-initiated deals this quarter. PE firms appear to be concentrating on integrating prior acquisitions or preparing for exits, rather than pursuing new investments. > What’s Next? Stay informed with Zensights as we keep you updated on the latest market movements and strategic shifts in the life sciences sector. #LifeSciences #MandA #IndustryTrends #ZensightsUpdate

We are excited to welcome Timothy Glennon as the newest Subject Matter Expert to join the Zensights team. With over 26 years in the industry, Tim brings a wealth of knowledge and expertise of the pharmaceutical industry to our organization. He has spent the last decade living and breathing all things pharma startups, following many successful years in large pharma. Tim has a unique perspective on corporate strategy, sales, marketing, commercial operations, and strategic planning. His proven track record of success in launching products, building teams, and driving revenue growth makes him an invaluable addition to our team.   Tim’s career journey began at Bayer, where he spent 14 years progressing swiftly through leadership positions, launching ~10 products, leading teams across 10 states, and securing new business development opportunities and partnerships. In 2012, Tim transitioned to Teva Pharmaceuticals, revitalizing their women’s health franchise. Under his leadership, and through his self-proclaimed obsession with P&L analysis and strategic planning, Tim’s team achieved a 50% revenue growth over three years. After much success at the largest manufacturer of generic drugs in the US, Tim’s next venture took him to a much different scale - the dynamic world of startups.   As VP of Sales and Marketing at Evofem Biosciences, Tim played a crucial role in building the company's commercial infrastructure. His responsibilities spanned sales, marketing, and sales operations, while also supporting clinical operations, and manufacturing. “In small pharma,” Tim shared, “you’re exposed to the entire organization. Whereas in large pharma you are siloed and I knew my vertical inside and out, with Evofem I was part of the leadership team engaging CMO and CRO partners, broadening my perspective of the entire pharmaceutical organization.” This exposure highlighted for him the importance of understanding the cost impact of each and every decision. 6 years later, Tim was serving as the Senior Vice President of Corporate Portfolio Strategy and Business Development, and Evofem had positioned itself as a leader in contraception, improving the lives of women worldwide. After his success at Evofem, Tim joined Veru Pharmaceuticals as their Executive Vice President of Sales, Marketing, and Sales Operations. There, he was responsible for developing and enhancing all aspects of sales and marketing strategy for their sexual health division.   Reflecting on his journey, Tim notes, "In today’s world, regulatory approval is not enough for commercial success; we must bridge drug development and commercial planning to truly succeed." As Tim joins Zensights as a SME, we are excited to leverage his expertise to guide small pharmaceutical companies through the complexities of drug development and commercialization. His passion for improving the lives of patients and driving business success will undoubtedly make a significant impact on our community. #ZensightsSME

Introducing Bob Roe, who has recently joined Zensights as a Subject Matter Expert! With a career spanning three decades and a remarkable talent for integrating sales and data science, Bob brings a wealth of experience that we are excited to have on board. Known for his expertise in market access and sales strategy, Bob's deep industry knowledge and innovative approach make him a valuable addition to our team.   Bob’s entry into the pharmaceutical world is rooted in his accounting background, combined with a natural disposition for sales. Beginning with an expansive territory in the West Coast, first as a Sales Rep, and then as a District Manager, Bob quickly made his mark growing sales and managing a motivated team. When Bob’s boss took a job with CSL Behring, she took Bob with her to run hospital sales. There, he led hospital reps across the southern US, and his region ranked #1 in total volume and volume increase each year over his four-year tenure. From CSL Behring, he was recruited to Watson Pharmaceuticals where he ran a region of 80-90 reps in the Midwest for about 7 years.    In 2010, Bob foresaw the rising importance of managed care and took the initiative to form a specialized team to tackle this emerging challenge. He founded Glacier Pharma and took on the task of understanding how managed care may impact the future of sales. “I saw that the future was large molecule injectables from a managed care and contracting perspective,” he shared. This foresight culminated in Glacier Pharma focusing on large molecule injectables and helping emerging companies navigate the US payer landscape. For the last decade, Bob has been in this role working with pharmaceutical manufacturers to contract with all payer types, ensuring access and ensuring that they are well-positioned in the market.   Bob's comprehensive knowledge of market access and his ability to develop and execute strategic sales strategies make him an exceptional addition to Zensights. We are excited to welcome Bob and look forward to the expertise he will bring to our community. #ZensightSME #MarketAccess #SalesStrategy

Happy Independence Day from Zensights! Wishing you a joyful 4th of July filled with celebration and pride. #IndependenceDay #FourthOfJuly

"Mission-based leadership is centralized understanding of intent, and decentralized implementation of execution. Trust is the holy grail."    At the core of mission-based leadership, highlighted at the last Zensights Leadership Summit, lies a simple approach: clearly define the mission and then trust your team to execute it.   ✓ Centralized Understanding of Intent: Ensure everyone understands the mission’s intent. This clarity aligns the team towards a common goal, creating a unified direction and eliminating ambiguity.    ✓ Decentralized Implementation of Execution: Great leaders trust their team to determine the best way to achieve the objectives. This unleashes creativity, initiative, and ownership, leading to more dynamic and effective problem-solving.    ✓ Trust as the Holy Grail: By empowering subordinates, leaders demonstrate their confidence in their team. When people feel trusted and valued, they are more likely to contribute their best efforts and insights.    #Leadership #MissionDriven #Empowerment #Trust #CollectiveIntelligence #ZensightsLeadershipSummit

Save the Date: December 13-14 Join us for the Zensights Leadership Summit in Washington, DC! This year's summit promises to be an extraordinary event, bringing together leaders from the pharmaceutical and military sectors for two days of insightful discussions and unparalleled networking opportunities. - One of the highlights will include attending the iconic Army-Navy game together as a group. - We have an incredible lineup of speakers, featuring pharma executives and distinguished military panelists who will share their insights and expertise. This event is invitation-only, but we encourage those hoping to attend to mark their calendars now. Stay tuned for more details! #ZensightsLeadershipSummit #PharmaLeadership #MilitaryLeadership #LeadershipEvent #SaveTheDate #WashingtonDC